ReviewSignal transduction and targeted therapy2024
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.
Xuhui Bao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
98 papers cite itlatest 60 shown
this paperpooled ittrialcites it